DarioHealth Corp. (DRIO) vs Renalytix plc - Sponsored ADR (RNLXY)
- DarioHealth Corp. DRIO 4.95 −3.51%
- Renalytix plc - Sponsored ADR RNLXY 3.50 +3.24%
DarioHealth Corp. and Renalytix plc - Sponsored ADR are both Health Information Services companies. DarioHealth Corp. is the larger, with a market value of $50.3M against $17.2M — 2.9× the size. Renalytix plc - Sponsored ADR grew revenue faster over the last twelve months: −18.3% against −22.7%. DarioHealth Corp. has the higher net margin (−215.6% vs −1,695.9%) and the lower return on invested capital (−27.7% vs 0.00%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 10 and DarioHealth Corp. on 6.
Valuation
Profitability
| Metric | DRIO | RNLXY | Health Information Services median |
|---|---|---|---|
| Gross margin | 58.15% | 14.52% | 62.87% |
| Operating margin | (151.60%) | (1,087.73%) | (9.45%) |
| Net margin | (215.63%) | (1,695.90%) | (15.48%) |
| Free cash flow margin | (121.32%) | 0.00% | 0.00% |
| Return on equity | (76.05%) | 0.00% | (6.91%) |
| Return on assets | (44.19%) | 0.00% | (6.28%) |
| Return on invested capital | (27.67%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack